Search

everythinglearnresearchcommunity

for

Search:↓

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

A woman was allergic to quinine in her anti-hair loss lotion.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

A 5-year-old girl's scalp scarring and hair loss from lupus improved with specific medications.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

AQB reduces harmful skin changes in systemic sclerosis.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

Understanding patients' views on their illness can help improve their disease management.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

The new treatment was safe and may effectively treat male pattern hair loss.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.